Ignite Creation Date:
2024-05-06 @ 8:10 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06287944
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-03-01
First Post:
2024-02-16
Brief Title:
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
Sponsor:
City of Hope Medical Center
Organization:
City of Hope Medical Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Myelodysplastic Syndrome |
| Acute Lymphoblastic Leukemia |
| Acute Myeloid Leukemia |
Keywords: